• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级血脂检测在心血管疾病预测中的作用。

The role of advanced lipid testing in the prediction of cardiovascular disease.

机构信息

Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9047, USA,

出版信息

Curr Atheroscler Rep. 2014 Mar;16(3):394. doi: 10.1007/s11883-013-0394-9.

DOI:10.1007/s11883-013-0394-9
PMID:24445969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4060612/
Abstract

Advanced lipid testing has been suggested by some experts to identify patients with substantial residual risk for more aggressive targeting of lifestyle and pharmacologic therapies. It measures the subpopulation of lipoproteins and apolipoproteins, which include lipoprotein (a), apolipoprotein A-I, and apolipoprotein B, and measures of lipoprotein particle composition such as LDL particle (LPL-P) and HDL particle (HDL-P) number and size. Obesity is associated with smaller LDL-P and HDL-P sizes. Moderate weight loss via fasting/calorie restriction is associated with LDL-P size increase, whereas moderate weight loss via endurance exercise is associated with HDL-P size increase. Diets high in carbohydrates are associated with a more atherogenic advanced lipoprotein profile characterized by smaller LDL-P and HDL-P sizes. In summary, lifestyle changes such as weight loss, exercise, and dietary modification correlate with improvement in the profile of advanced lipoproteins. Regrettably, therapies targeting HDL and HDL composition have been disappointing to date.

摘要

一些专家建议进行高级血脂检测,以确定具有更大残余风险的患者,从而更积极地针对生活方式和药物治疗进行靶向治疗。它测量脂蛋白和载脂蛋白的亚群,包括脂蛋白(a)、载脂蛋白 A-I 和载脂蛋白 B,以及脂蛋白颗粒组成的测量,如 LDL 颗粒 (LPL-P) 和 HDL 颗粒 (HDL-P) 的数量和大小。肥胖与较小的 LDL-P 和 HDL-P 大小有关。通过禁食/热量限制适度减肥与 LDL-P 大小增加有关,而通过耐力运动适度减肥与 HDL-P 大小增加有关。富含碳水化合物的饮食与更具动脉粥样硬化性的先进脂蛋白谱有关,其特征是 LDL-P 和 HDL-P 大小较小。总之,生活方式的改变,如减肥、运动和饮食调整,与先进脂蛋白谱的改善相关。遗憾的是,迄今为止,针对 HDL 和 HDL 组成的治疗方法一直令人失望。

相似文献

1
The role of advanced lipid testing in the prediction of cardiovascular disease.高级血脂检测在心血管疾病预测中的作用。
Curr Atheroscler Rep. 2014 Mar;16(3):394. doi: 10.1007/s11883-013-0394-9.
2
Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial).在高甘油三酯血症患者中比较免疫测定法、磁共振、垂直自动轮廓和非高密度脂蛋白胆固醇估算的载脂蛋白 B 水平(SAFARI 试验)。
Am J Cardiol. 2011 Jul 1;108(1):40-6. doi: 10.1016/j.amjcard.2011.03.003. Epub 2011 May 10.
3
Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.非诺贝特对IIB型高脂血症患者极低密度脂蛋白-1颗粒数目的优先降低作用:对人单核细胞衍生巨噬细胞脂质蓄积的影响
Atherosclerosis. 2001 Mar;155(1):251-60. doi: 10.1016/s0021-9150(00)00634-1.
4
Comparison of effects of diet versus exercise weight loss regimens on LDL and HDL particle size in obese adults.比较饮食与运动减肥方案对肥胖成年人 LDL 和 HDL 颗粒大小的影响。
Lipids Health Dis. 2011 Jul 18;10:119. doi: 10.1186/1476-511X-10-119.
5
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.降低“极高”ASCVD 风险患者的靶向致动脉粥样硬化脂蛋白胆固醇目标。
Curr Diab Rep. 2019 Nov 21;19(12):146. doi: 10.1007/s11892-019-1246-y.
6
Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.与吉非贝齐在高胆固醇喂养大鼠中血浆脂质调节活性相关的载脂蛋白变化。
J Lipid Res. 1985 Aug;26(8):940-9.
7
Ability of non-high-density lipoprotein cholesterol and calculated intermediate-density lipoprotein to identify nontraditional lipoprotein subclass risk factors in dialysis patients.非高密度脂蛋白胆固醇和计算得出的中间密度脂蛋白识别透析患者非传统脂蛋白亚类危险因素的能力。
Am J Kidney Dis. 2004 Feb;43(2):320-9. doi: 10.1053/j.ajkd.2003.10.019.
8
The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia.治疗动脉粥样硬化性血脂异常的代谢和药理学基础。
Best Pract Res Clin Endocrinol Metab. 2014 Jun;28(3):369-85. doi: 10.1016/j.beem.2013.10.001. Epub 2013 Oct 9.
9
Mechanism of action of gemfibrozil on lipoprotein metabolism.吉非贝齐对脂蛋白代谢的作用机制。
J Clin Invest. 1985 May;75(5):1702-12. doi: 10.1172/JCI111879.
10
Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).二十碳五烯酸乙酯,一种纯 EPA 欧米伽-3 脂肪酸:对极高甘油三酯水平患者脂蛋白颗粒浓度和大小的影响(MARINE 研究)。
J Clin Lipidol. 2012 Nov-Dec;6(6):565-72. doi: 10.1016/j.jacl.2012.07.001. Epub 2012 Jul 24.

引用本文的文献

1
Clinical Relevance of Nuclear Magnetic Resonance LipoProfile.核磁共振脂质谱的临床相关性
Front Nucl Med. 2022 Jul 13;2:960522. doi: 10.3389/fnume.2022.960522. eCollection 2022.
2
High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine.降脂治疗后仍存在较高心血管残余风险:预测性、预防性、个性化、参与性及心理认知医学的黄金时期。
Front Cardiovasc Med. 2023 Oct 16;10:1264319. doi: 10.3389/fcvm.2023.1264319. eCollection 2023.
3
The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.高密度脂蛋白亚组份和亚种的区别:心血管疾病和糖尿病中不断发展的模型。
Curr Atheroscler Rep. 2021 Mar 27;23(6):23. doi: 10.1007/s11883-021-00925-4.
4
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science.利用先进血脂检测评估动脉粥样硬化性心血管疾病风险:科学现状
Eur Cardiol. 2020 Jul 15;15:e56. doi: 10.15420/ecr.2019.18. eCollection 2020 Feb.
5
Prognostic value of lipid profiles after radical prostatectomy: a systematic review and meta-analysis.根治性前列腺切除术后血脂谱的预后价值:系统评价和荟萃分析。
Lipids Health Dis. 2019 May 28;18(1):124. doi: 10.1186/s12944-019-1068-6.
6
High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes.健康与人类疾病中的高密度脂蛋白亚类:聚焦2型糖尿病
Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):55-61. doi: 10.14797/mdcj-15-1-55.
7
Gender and Age Stratified Analyses of Nutrient and Dietary Pattern Associations with Circulating Lipid Levels Identify Novel Gender and Age-Specific Correlations.性别和年龄分层分析营养素和饮食模式与循环脂质水平的关系,确定新的性别和年龄特异性相关性。
Nutrients. 2018 Nov 14;10(11):1760. doi: 10.3390/nu10111760.
8
Revisiting "Good" and "Bad" Cholesterol. The Battle over Flow through Arteries Now Shifts to Flow through Airways.重新审视“好”胆固醇与“坏”胆固醇。动脉血流之争如今转向气道血流。
Am J Respir Crit Care Med. 2015 May 1;191(9):969-70. doi: 10.1164/rccm.201502-0413ED.
9
Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy.高甘油三酯血症是根治性前列腺切除术后生化复发的一个潜在术前预测指标。
PLoS One. 2015 Mar 24;10(3):e0122438. doi: 10.1371/journal.pone.0122438. eCollection 2015.
10
Impact of estimated HDL particle size via the ratio of HDL-C and apoprotein A-I on short-term prognosis of diabetic patients with stable coronary artery disease.基于高密度脂蛋白胆固醇与载脂蛋白 A-I 比值估算的高密度脂蛋白颗粒大小对稳定型冠状动脉疾病糖尿病患者短期预后的影响。
J Geriatr Cardiol. 2014 Sep;11(3):245-52. doi: 10.11909/j.issn.1671-5411.2014.03.015.

本文引用的文献

1
High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy.高密度脂蛋白胆固醇、大小、颗粒数与强效他汀治疗后的残余血管风险。
Circulation. 2013 Sep 10;128(11):1189-97. doi: 10.1161/CIRCULATIONAHA.113.002671. Epub 2013 Sep 3.
2
Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program.生活方式和二甲双胍治疗对糖尿病预防计划中的脂蛋白亚组分分布有有利影响。
J Clin Endocrinol Metab. 2013 Oct;98(10):3989-98. doi: 10.1210/jc.2013-1452. Epub 2013 Aug 26.
3
Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).载脂蛋白 A-1 和 B 以及脂蛋白(a)与心血管结局的关系:AIM-HIGH 试验(代谢综合征伴低 HDL/高甘油三酯血症的动脉粥样硬化血栓形成干预及其对全球健康结局的影响)。
J Am Coll Cardiol. 2013 Oct 22;62(17):1575-9. doi: 10.1016/j.jacc.2013.06.051. Epub 2013 Aug 21.
4
Systematic review: Evaluating the effect of lipid-lowering therapy on lipoprotein and lipid values.系统评价:评估降脂治疗对脂蛋白和血脂值的影响。
Cardiovasc Drugs Ther. 2013 Oct;27(5):465-79. doi: 10.1007/s10557-013-6477-6.
5
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.HPS2-THRIVE 随机安慰剂对照试验纳入 25673 例 ER 烟酸/拉罗匹仑的高危患者:试验设计、预先指定的肌肉和肝脏结局以及停止研究治疗的原因。
Eur Heart J. 2013 May;34(17):1279-91. doi: 10.1093/eurheartj/eht055. Epub 2013 Feb 26.
6
Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans.隔日禁食和耐力运动相结合可降低肥胖人群的体重,并改善其血浆脂质水平。
Obesity (Silver Spring). 2013 Jul;21(7):1370-9. doi: 10.1002/oby.20353. Epub 2013 May 29.
7
Effects of dalcetrapib in patients with a recent acute coronary syndrome.近期急性冠脉综合征患者应用达塞曲匹的效果。
N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.
8
Whole egg consumption improves lipoprotein profiles and insulin sensitivity to a greater extent than yolk-free egg substitute in individuals with metabolic syndrome.与无蛋黄的鸡蛋替代品相比,全蛋摄入能更大程度地改善代谢综合征个体的脂蛋白谱和胰岛素敏感性。
Metabolism. 2013 Mar;62(3):400-10. doi: 10.1016/j.metabol.2012.08.014. Epub 2012 Sep 27.
9
High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).高密度脂蛋白胆固醇和颗粒浓度、颈动脉粥样硬化和冠状动脉事件:MESA(动脉粥样硬化的多民族研究)。
J Am Coll Cardiol. 2012 Aug 7;60(6):508-16. doi: 10.1016/j.jacc.2012.03.060. Epub 2012 Jul 11.
10
Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in Studies of a Targeted Risk Reduction Intervention through Defined Exercise I.不同饮食模式人群的运动对血脂的影响——如果他们运动,饮食是否重要?通过明确的运动干预来靶向降低风险的研究 I 的反应。
Am Heart J. 2012 Jul;164(1):117-24. doi: 10.1016/j.ahj.2012.04.014.